Yanagita T, Murata Y, Tanaka D, Motegi S, Arai E, Daniwijaya E, et al. Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2017;2:e89140 pubmed publisher

Zen K, Guo Y, Bian Z, Lv Z, Zhu D, Ohnishi H, et al. Inflammation-induced proteolytic processing of the SIRPα cytoplasmic ITIM in neutrophils propagates a proinflammatory state. Nat Commun. 2013;4:2436 pubmed publisher

Koskinen C, Persson E, Baldock P, Stenberg A, Boström I, Matozaki T, et al. Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein ? (SIRP?) signaling. J Biol Chem. 2013;288:29333-44 pubmed publisher

Teraoka Y, Ide K, Morimoto H, Tahara H, Ohdan H. Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRP? inhibitory signaling in mice. PLoS ONE. 2013;8:e58359 pubmed publisher

Lundberg P, Koskinen C, Baldock P, Löthgren H, Stenberg A, Lerner U, et al. Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction. Biochem Biophys Res Commun. 2007;352:444-8 pubmed

Oldenborg P, Gresham H, Lindberg F. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med. 2001;193:855-62 pubmed